BENDAMUSTINE HYDROCHLORIDE
NDC 83831-183, bendamustine hydrochloride, injection, from Avyxa Pharma, LLC.
- Product NDC
- 83831-183
- Status
- Listed
- Labeler
- Avyxa Pharma, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219014
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83831-183 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENDAMUSTINE HYDROCHLORIDE100 mg/4mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83831-183-04 | 83831018304 | 1 VIAL in 1 CARTON (83831-183-04) / 4 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f359e7c6-d104-457d-a7fe-597c74440353
Use it
Look up 83831-183 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83831-183 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83831-183. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.